Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity
Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 ...
Novo Nordisk A/S (NVO) Dropped as Trial Results Fell Short of Expectations
Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor ...
Donald Trump’s $1.4 trillion tariff threats scramble business plans, US companies form task-forces to tackle impact
Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...
Amid Market Turmoil, Compelling Earnings Coming
Investors looking for safe havens in a dangerous market. China EV players, FedEx and Micron earnings next week.
The Pharma Letter6d
The week in pharma: action, reaction and insight – week to March 14
The American Academy of Dermatology (AAD) meeting last week continued to provide positive news, including from US biotech ...
Bristol Myers Squibb scoops up 2seventy bio for $286M
Less than a month after the company from which it split more than three years ago, bluebird bio, sold for less than $30 million, the Cambridge drugmaker is being acquired by its partner Bristol Myers ...
Europe markets close lower; Stellantis drops 5% after Trump threatens Canadian auto manufacturing
European markets closed lower as global markets buckle amid anxiety that the U.S. economy will suffer because of Trump’s ...
STAT11d
Bristol buys out cancer cell therapy partner
Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...
Trump’s $1.4 trillion tariff threat spurs companies to seek cover
Companies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trumps tariffs. Executives ...